Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksForterra Regulatory News (FORT)

Share Price Information for Forterra (FORT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 177.20
Bid: 177.00
Ask: 177.40
Change: 5.00 (2.90%)
Spread: 0.40 (0.226%)
Open: 170.00
High: 178.20
Low: 170.00
Prev. Close: 172.20
FORT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Post close half year trading update

11 Jul 2023 07:00

RNS Number : 5661F
Forterra plc
11 July 2023
 

11 July 2023

 

FORTERRA PLC

 

Post close half year trading update

 

In advance of the publication of our half year results on 27 July 2023 Forterra plc (the 'Group'), a leading UK manufacturer of essential clay and concrete building products, provides this trading update for the six-month period ending 30 June 2023 (the 'period').

 

Key points

 

· Resilient H1 results broadly in line with our expectations, delivered against a backdrop of challenging trading conditions

· We expect to report H1 revenues of approximately £183m, adjusted EBITDA of approximately £30m and adjusted PBT of approximately £18m

· Progressive signs of market improvement seen through May and June, although this improvement has been less pronounced than previously anticipated

· Considering the increasingly uncertain macroeconomic outlook we now expect to deliver full year 2023 EBITDA with a more balanced H1 / H2 split, reflecting only a modest improvement in trading conditions in H2

 

H1 results

 

· Subject to review by our auditors, we expect to report revenues for the period of approximately £183m, a decrease of 18% relative to the prior year (2022: £222.8m)

· We expect to report a resilient H1 result broadly in line with management expectations, with adjusted EBITDA of approximately £30m (2022: £46.1m) and adjusted PBT of approximately £18m (2022: £37.3m)

· Whilst market conditions remain competitive, our selling prices have remained firm and our cost base stable

· As planned, we have rebuilt our inventory, with stock levels increasing by approximately £30m in the period, leaving us well placed to deliver the service levels our customers expect

· We have maintained a strong and flexible balance sheet and expect to report a period end net debt before leases of approximately £50m (2022 year end: £5.9m) which is below 1x adjusted EBITDA on a LTM basis

 

Management actions

 

· In response to the challenging market conditions, and with our brick production capacity increasing with the opening of the new Desford factory, as previously announced, we have mothballed our Howley Park brick factory and implemented other production reductions which will reduce our fixed costs by around £10m on an annualised basis

· In addition, we are consulting with affected individuals on a restructuring of our commercial and support functions, aligning them to anticipated demand, which we expect to save approximately £3m annually

· The demand for our products in H2 will influence our production decisions. Having replenished our inventories in H1 we expect to limit our inventory growth in H2 and will continue to take appropriate action to ensure our output is aligned to demand

· Our strategy remains to maximise the ramp up of production at the new Desford factory, such that we can benefit from the market leading efficiencies it will offer once fully commissioned

 

Market backdrop and outlook

 

· UK brick industry despatches, as published by the Department of Business and Trade, were 31% adverse to the prior year in the five months to May 2023, with the month of May showing signs of an improving trend which is further evidenced by our own despatches for June, albeit this improvement is less pronounced than previously anticipated

· Encouragingly, imports of bricks to the UK have fallen significantly, decreasing 44% relative to 2022 in the four months to April, although they still remain high as a proportion of overall demand

· Although customer inventory reduction has been more prolonged than anticipated, we still expect this to ease in H2

· Demand for our products for the rest of the year remains subject to significant uncertainty with rising interest rates widely expected to adversely impact the demand for new homes for the foreseeable future

· Contrary to the wider macroeconomic backdrop, our precast flooring business, which can be regarded as a leading indicator for future brick and block demand is performing strongly, with despatches presently only 20% below prior year levels with current order intake running ahead of this

· As set out at the start of the year, our expectations for 2023 were based upon an underlying fall in full year market demand of 20% relative to 2022, with a slow start to the year followed by a meaningful recovery strengthening into H2 

· However, we are now assuming only a modest improvement in trading conditions, and therefore expect to deliver full year EBITDA with a more balanced H1 / H2 split

· The impacts of greater borrowing, inventory build, and rising interest rates are also expected to drive an increase in our financing costs

· Notwithstanding a weaker market in the short-term, looking further ahead, the Board remains confident that the Group remains well positioned to benefit from attractive market fundamentals of a shortage of UK housing supply, a shortfall of domestic brick production capacity and cross-party political support for increasing housing supply

 

This announcement contains inside information for the purposes of article 7 of the Market Abuse Regulation (EU) No 596/2014.

 

ENQUIRIES

 

Forterra plc +44 1604 707 600

Neil Ash, Chief Executive Officer

Ben Guyatt, Chief Financial Officer

 

FTI Consulting +44 203 727 1340

Richard Mountain / Nick Hasell

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFZGMNRGRGFZM
Date   Source Headline
15th Jun 20219:56 amRNSDirector/PDMR Shareholding
7th Jun 20219:24 amRNSEmployee Benefit Trust Share Purchase
27th May 20213:45 pmRNSDirector/PDMR Shareholding
18th May 20213:45 pmRNSAnnual General Meeting 2021 Results
18th May 202110:28 amRNSProgressive publishes new research
18th May 20217:00 amRNSTrading Statement
6th May 20217:00 amRNSEmployee Benefit Trust Share Purchase
30th Apr 20214:07 pmRNSHolding(s) in Company
30th Apr 20211:11 pmRNSGrant under Performance Share Plan
9th Apr 20213:46 pmRNSDirector/PDMR Shareholding
9th Apr 202110:56 amRNSHolding(s) in Company
9th Apr 20217:00 amRNSAnnual Report 2020 and Notice of AGM 2021
8th Apr 20213:31 pmRNSEmployee Benefit Trust Share Purchase
1st Apr 202110:59 amRNSDirector/PDMR Shareholding
30th Mar 20211:14 pmRNSDirector/PDMR Shareholding
25th Mar 20212:41 pmRNSDirector/PDMR Shareholding
22nd Mar 20213:55 pmRNSDirector/PDMR Shareholding
11th Mar 20217:00 amRNSDirector/PDMR Shareholding
9th Mar 20217:00 amRNS2020 FULL YEAR RESULTS
4th Mar 20217:24 amRNSHolding(s) in Company
3rd Mar 202110:36 amRNSHolding(s) in Company
2nd Mar 20217:00 amRNSEmployee Benefit Trust Share Purchase
17th Feb 20213:16 pmRNSHolding(s) in Company
15th Feb 20217:00 amRNSDirector/PDMR Shareholding
8th Feb 20212:16 pmRNSDirector/PDMR Shareholding
2nd Feb 20214:17 pmRNSEmployee Benefit Trust Share Purchase
1st Feb 20214:48 pmRNSDirector/PDMR Shareholding
28th Jan 202112:38 pmRNSHolding(s) in Company
27th Jan 20213:40 pmRNSHolding(s) in Company
26th Jan 20218:15 amRNSProgressive publishes new research
26th Jan 20217:00 amRNSTrading Statement
6th Jan 20217:21 amRNSEmployee Benefit Trust Share Purchase
6th Jan 20217:21 amRNSDirector/PDMR Shareholding
4th Jan 20219:29 amRNSHolding(s) in Company
8th Dec 20202:28 pmRNSEmployee Benefit Trust Share Purchase
27th Nov 20207:00 amRNSEmployee Benefit Trust Share Purchase
24th Nov 20201:00 pmRNSEmployee Benefit Trust Share Purchase
24th Nov 20208:24 amRNSProgressive publishes new research
24th Nov 20207:00 amRNSTrading Statement
5th Nov 20205:09 pmRNSHolding(s) in Company
9th Oct 20203:45 pmRNSGrant of Options under 2020 SAYE Scheme
18th Sep 202010:12 amRNSGrant under Performance Share Plan
18th Sep 20209:40 amRNSHolding(s) in Company
14th Sep 20201:50 pmRNSProgressive publishes new research
14th Sep 20209:05 amRNSHolding(s) in Company
10th Sep 20207:00 amRNS2020 HALF YEAR RESULTS
7th Sep 20205:34 pmRNSHolding(s) in Company
14th Aug 20201:45 pmRNSHolding(s) in Company
30th Jul 20204:54 pmRNSHolding(s) in Company
16th Jul 202010:09 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.